These findings indicate unique mechanisms of SIRT1 mediate BC regulation and its contribution to tumor development and resistance, which suggests that SIRTs are promising therapeutic targets in BC, and provides clinical strategy for overcoming drug resistance. The gene discussed is SIRT1; the disease is neoplasm.